Compare Elder Pharma with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA FRESENIUS KABI ONCO. ELDER PHARMA/
FRESENIUS KABI ONCO.
 
P/E (TTM) x -0.2 22.1 - View Chart
P/BV x 0.1 3.1 3.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ELDER PHARMA   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
FRESENIUS KABI ONCO.
Mar-13
ELDER PHARMA/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs380176 215.9%   
Low Rs18879 239.5%   
Sales per share (Unadj.) Rs491.237.7 1,303.4%  
Earnings per share (Unadj.) Rs-3.25.1 -62.5%  
Cash flow per share (Unadj.) Rs14.46.7 214.3%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.542.5 885.0%  
Shares outstanding (eoy) m20.54158.23 13.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.63.4 17.1%   
Avg P/E ratio x-89.325.0 -357.3%  
P/CF ratio (eoy) x19.718.9 104.1%  
Price / Book Value ratio x0.83.0 25.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,83320,135 29.0%   
No. of employees `000NA1.2 0.0%   
Total wages/salary Rs m2,179703 309.9%   
Avg. sales/employee Rs ThNM5,176.2-  
Avg. wages/employee Rs ThNM610.4-  
Avg. net profit/employee Rs ThNM699.6-  
INCOME DATA
Net Sales Rs m10,0895,963 169.2%  
Other income Rs m25718 1,425.6%   
Total revenues Rs m10,3465,981 173.0%   
Gross profit Rs m-7921,430 -55.4%  
Depreciation Rs m361258 140.1%   
Interest Rs m2,756-26 -10,601.2%   
Profit before tax Rs m-3,6531,216 -300.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,713-68 -5,451.8%   
Tax Rs m125342 36.6%   
Profit after tax Rs m-65806 -8.1%  
Gross profit margin %-7.824.0 -32.7%  
Effective tax rate %-3.428.1 -12.2%   
Net profit margin %-0.613.5 -4.8%  
BALANCE SHEET DATA
Current assets Rs m9,2405,102 181.1%   
Current liabilities Rs m9,9982,385 419.1%   
Net working cap to sales %-7.545.6 -16.5%  
Current ratio x0.92.1 43.2%  
Inventory Days Days46150 30.9%  
Debtors Days Days60113 52.9%  
Net fixed assets Rs m10,1245,148 196.6%   
Share capital Rs m206158 130.0%   
"Free" reserves Rs m5,5826,556 85.2%   
Net worth Rs m7,7346,732 114.9%   
Long term debt Rs m4,889952 513.4%   
Total assets Rs m22,88210,388 220.3%  
Interest coverage x-0.3-45.8 0.7%   
Debt to equity ratio x0.60.1 446.9%  
Sales to assets ratio x0.40.6 76.8%   
Return on assets %11.87.5 156.6%  
Return on equity %-0.812.0 -7.1%  
Return on capital %22.314.6 152.8%  
Exports to sales %3.074.5 4.1%   
Imports to sales %0.424.8 1.7%   
Exports (fob) Rs m3074,441 6.9%   
Imports (cif) Rs m431,477 2.9%   
Fx inflow Rs m3075,298 5.8%   
Fx outflow Rs m1251,772 7.1%   
Net fx Rs m1813,525 5.1%   
CASH FLOW
From Operations Rs m11,7541,274 922.5%  
From Investments Rs m-561-1,204 46.5%  
From Financial Activity Rs m-6,762-196 3,448.1%  
Net Cashflow Rs m4,432-126 -3,508.9%  

Share Holding

Indian Promoters % 39.6 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 7.5 0.3 2,500.0%  
FIIs % 16.8 9.6 175.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 9.1 396.7%  
Shareholders   16,479 42,599 38.7%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   DISHMAN PHARMA  CADILA HEALTHCARE  SUVEN LIFESCIENCES  ALEMBIC PHARMA  WOCKHARDT  

Compare ELDER PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Sensex Ends 187 Points Higher(Closing)

Indian share markets end on a positive note with the Sensex up by 187 points, while the Nifty closed up by 36 points.

Related Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS